Enco Pharmaceutical Development
UEI: ZR4EP2W1C673
• CAGE: 7XC70
• DBA: EPDI
Overview
Parent Awardee
Federal Capability Statement
ENCO Pharmaceutical Development, Inc (EPDI) provides comprehensive product development services to the pharmaceutical and medical device market.
From its locations in Jacksonville FL and Cary NC, we provide customers around the world with high quality analytical services, comprehensive stability storage and related testing, as well as a full complement of product and formulation development services.
Keywords
Method Development and Validation, Stability, Analytical Testing, Compendial, Release Testing, Formulation Development
Website
Headquarters
Jacksonville, FL
United States
United States
Federal recipient
ENCO PHARMACEUTICAL DEVELOPMENT, INC.
dba EPDI
(UEI ZR4EP2W1C673, CAGE 7XC70)
is headquartered in Jacksonville FL.
Its primary registered NAICS is 541380 Testing Laboratories and Services.
The corporation
was founded in January 2005 and
federally registered in
July 2017.
Federal Registration and Certifications
Legal Name
ENCO PHARMACEUTICAL DEVELOPMENT, INC.
DBA
EPDI
UEI
ZR4EP2W1C673
CAGE Code
7XC70
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 3, 2005
Initial Registration
July 31, 2017
Last Registration
June 7, 2023
Registration Activation
June 9, 2022
Registration Expiration
June 7, 2023
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Subchapter S Corporation
Subchapter S Corporation
State of Incorporation
FL
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes